Lipocine Inc (LPCN)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current LPCN market cap is 32.7M. The company's latest EPS is USD -3.0576 and P/E is -2.04.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 55k | 0 | 0 | -2.91M | 7.62M |
| Operating Income | -4.34M | -3.96M | -7.04M | -2.59M | 3.22M |
| Net Income | -3.87M | -3.55M | -6.65M | -2.28M | 3.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 165k | 0 | 16.14M | 500k | -2.85M |
| Operating Income | -12.9M | -18M | 3.15M | -12.12M | -17.93M |
| Net Income | -13.01M | -20.97M | -634k | -10.76M | -16.35M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 34.02M | 30.48M | 24.75M | 23M | 25.45M |
| Total Liabilities | 2.06M | 1.93M | 2.27M | 2.63M | 1.49M |
| Total Equity | 31.96M | 28.55M | 22.48M | 20.37M | 23.96M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 19.66M | 25.35M | 52.48M | 37.54M | 23M |
| Total Liabilities | 13.37M | 10.01M | 6.91M | 1.91M | 2.63M |
| Total Equity | 6.29M | 15.34M | 45.57M | 35.64M | 20.37M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -3.93M | -7.24M | -9.84M | -11.87M | 2.41M |
| Investing | 5.56M | 9.12M | 10.36M | 13.09M | -4.09M |
| Financing | -6k | -11k | 410k | 405k | -8k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.67M | -15.3M | -4.41M | -11.97M | -11.87M |
| Investing | 3M | 3.89M | -43.78M | 14.29M | 13.09M |
| Financing | 10.32M | 20.9M | 26.93M | -2.13M | 405k |
| Market Cap | 32.7M |
| Price to Earnings Ratio | -2.04 |
| Price to Sales Ratio | -11.71 |
| Price to Cash Ratio | 6.99 |
| Price to Book Ratio | 1.64 |
| Dividend Yield | - |
| Shares Outstanding | 5.35M |
| Average Volume (1 week) | 54.42k |
| Average Volume (1 Month) | 40.65k |
| 52 Week Change | 45.25% |
| 52 Week High | 11.79 |
| 52 Week Low | 2.3101 |
| Spread (Intraday) | 0.27 (4.24%) |
| Company Name | Lipocine Inc |
| Address |
919 north market street wilmington, delaware 19801 |
| Website | https://www.lipocine.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
